ORIGINAL RESEARCH
Published on 03 Nov 2025
Relapsed or refractory central nervous system lymphoma successfully treated by glofitamab combined with lenalidomide
doi 10.3389/fonc.2025.1685271
- 1,203 views
- Frontiers in Hematology
- Blood Cancer
- Research Topics
- New molecular targets for personalized treatment for Low-Grade Non-Hodgkin Lymphoma
New molecular targets for personalized treatment for Low-Grade Non-Hodgkin Lymphoma
1,418
Total downloads
9,724
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Published on 16 Jul 2025
The therapeutic perspective of relapsed/refractory Waldenström Macroglobulinemia: what comes next?
doi 10.3389/frhem.2025.1624046
- 2,029 views
ORIGINAL RESEARCH
Published on 16 Apr 2025
Dual targeting of EZH2 and PD-L1 in Burkitt’s lymphoma enhances immune activation and induces apoptotic pathway
doi 10.3389/fimmu.2025.1578665
- 3,785 views
- 1 citation
Published in
Frontiers in Hematology
Blood Cancer
Other participating journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: